Everence Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,990
| Closed | -$155K | – | 806 |
|
|
2023
Q2 | $155K | Hold |
25,990
| – | – | 0.01% | 685 |
|
|
2023
Q1 | $176 | Hold |
25,990
| – | – | 0.01% | 705 |
|
|
2022
Q4 | $192 | Buy |
25,990
+15,100
| +139% | +$112 | 0.02% | 701 |
|
|
2022
Q3 | $108K | Hold |
10,890
| – | – | 0.01% | 709 |
|
|
2022
Q2 | $119K | Hold |
10,890
| – | – | 0.01% | 704 |
|
|
2022
Q1 | $123K | Hold |
10,890
| – | – | 0.01% | 724 |
|
|
2021
Q4 | $171K | Hold |
10,890
| – | – | 0.01% | 742 |
|
|
2021
Q3 | $187K | Hold |
10,890
| – | – | 0.02% | 705 |
|
|
2021
Q2 | $234K | Hold |
10,890
| – | – | 0.02% | 649 |
|
|
2021
Q1 | $164K | Hold |
10,890
| – | – | 0.01% | 703 |
|
|
2020
Q4 | $143K | Hold |
10,890
| – | – | 0.01% | 683 |
|
|
2020
Q3 | $105K | Hold |
10,890
| – | – | 0.01% | 663 |
|
|
2020
Q2 | $128K | Hold |
10,890
| – | – | 0.02% | 626 |
|
|
2020
Q1 | $113K | Buy |
+10,890
| New | +$113K | 0.02% | 577 |
|